Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,049 | 64 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $197.91 | 12 | $0 (2024) |
| PFIZER INC. | $197.26 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $102.99 | 6 | $0 (2024) |
| ABBVIE INC. | $91.05 | 5 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $68.45 | 4 | $0 (2024) |
| Allergan, Inc. | $64.83 | 4 | $0 (2020) |
| Gilead Sciences, Inc. | $64.22 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $57.87 | 4 | $0 (2024) |
| Mylan Specialty L.P. | $46.22 | 3 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $36.95 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $219.10 | 12 | PFIZER INC. ($61.49) |
| 2023 | $266.07 | 16 | Lexicon Pharmaceuticals, Inc. ($52.07) |
| 2022 | $82.86 | 5 | Novartis Pharmaceuticals Corporation ($37.06) |
| 2021 | $84.61 | 5 | Janssen Pharmaceuticals, Inc ($35.55) |
| 2020 | $104.81 | 7 | PFIZER INC. ($43.48) |
| 2019 | $234.72 | 15 | Janssen Pharmaceuticals, Inc ($68.74) |
| 2017 | $57.12 | 4 | PFIZER INC. ($30.27) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: COVID-19 | ||||||
| 11/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: COVID-19 | ||||||
| 10/22/2024 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/14/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Gastroenterology | ||||||
| 05/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/07/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.38 | General |
| 04/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/15/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/28/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: COVID-19 | ||||||
| 11/26/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/16/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: COVID-19 | ||||||
| 11/15/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Rare Disease | ||||||
| 11/14/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: DIABETES | ||||||
| 09/15/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 08/21/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 08/02/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 06/22/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/13/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Rare Disease | ||||||
| 06/09/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/02/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/07/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 716 | 920 | $315,752 | $95,805 |
| 2022 | 12 | 600 | 801 | $247,190 | $76,662 |
| 2021 | 11 | 661 | 1,023 | $230,298 | $74,404 |
| 2020 | 8 | 650 | 942 | $256,369 | $86,976 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 346 | 360 | $173,160 | $48,249 | 27.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 163 | 297 | $78,300 | $27,074 | 34.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 98 | 100 | $27,056 | $8,853 | 32.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 50 | 104 | $18,207 | $6,402 | 35.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 48 | $15,648 | $4,388 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 11 | $3,381 | $839.30 | 24.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 174 | 177 | $85,137 | $25,995 | 30.5% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 91 | 92 | $40,388 | $12,506 | 31.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 72 | 215 | $36,980 | $11,789 | 31.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 81 | 132 | $32,736 | $10,383 | 31.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 45 | 45 | $11,970 | $3,696 | 30.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 27 | 27 | $8,802 | $2,635 | 29.9% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 27 | 27 | $8,721 | $2,273 | 26.1% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 16 | 16 | $6,512 | $2,197 | 33.7% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 17 | 20 | $4,980 | $1,609 | 32.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 24 | 24 | $4,152 | $1,366 | 32.9% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 15 | 15 | $4,172 | $1,357 | 32.5% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $2,640 | $855.49 | 32.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 155 | 380 | $65,016 | $21,359 | 32.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 95 | 146 | $35,852 | $11,534 | 32.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 73 | 73 | $34,959 | $11,478 | 32.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 118 | 121 | $32,186 | $9,856 | 30.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 39 | 39 | $12,614 | $4,060 | 32.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 28 | 28 | $12,244 | $3,886 | 31.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 43 | 113 | $10,493 | $3,422 | 32.6% |
About Dr. Taleb Taha, M.D
Dr. Taleb Taha, M.D is a Hospitalist healthcare provider based in Bismarck, North Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2010. The National Provider Identifier (NPI) number assigned to this provider is 1407161003.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Taleb Taha, M.D has received a total of $1,049 in payments from pharmaceutical and medical device companies, with $219.10 received in 2024. These payments were reported across 64 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,049).
As a Medicare-enrolled provider, Taha has provided services to 2,627 Medicare beneficiaries, totaling 3,686 services with total Medicare billing of $333,847. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Family Medicine
- Location Bismarck, ND
- Active Since 08/09/2010
- Last Updated 07/30/2025
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1407161003
Products in Payments
- XARELTO (Drug) $197.91
- ELIQUIS (Drug) $197.26
- ENTRESTO (Drug) $86.59
- DALVANCE (Drug) $82.08
- TEFLARO (Drug) $73.80
- Veklury (Drug) $64.22
- Inpefa (Drug) $52.07
- Yupelri (Drug) $46.22
- JARDIANCE (Drug) $36.95
- FARXIGA (Drug) $31.44
- ULTOMIRIS (Biological) $29.52
- BRILINTA (Drug) $26.43
- Wegovy (Drug) $19.58
- XIFAXAN (Drug) $19.55
- LEQVIO (Drug) $16.40
- PNEUMOVAX 23 (Biological) $16.13
- Vabomere (Drug) $14.91
- NUPLAZID (Drug) $11.13
- Veltassa (Drug) $10.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Bismarck
Hai Xu, Md, MD
Hospitalist — Payments: $18,973
Makda Bsrat, Md, MD
Hospitalist — Payments: $1,687
Dr. Issa Al Rabadi, M.d, M.D
Hospitalist — Payments: $742.07
Dr. Khris Ramdeen, Md, MD
Hospitalist — Payments: $628.15
Renae Welhouse, Acnpc-Ag, ACNPC-AG
Hospitalist — Payments: $623.20
Dr. Candice Crichlow, M.d, M.D
Hospitalist — Payments: $433.38